Bladder Cancer

Muscle-Invasive Bladder Cancer in Non-Curative Patients: A Study on Survival and Palliative Care Needs - Beyond the Abstract November 27, 2024

Perioperative Complications and In-Hospital Mortality in Paraplegic Radical Cystectomy Patients - Beyond the Abstract November 21, 2024

Perioperative Platform for Muscle-Invasive Bladder Cancer Trials: Designs and Endpoints - Beyond the Abstract November 21, 2024

Bladder Sparing Options for Muscle-Invasive Bladder Cancer - Beyond the Abstract November 20, 2024

Modulation of the Tumor Microenvironment in Non-Muscle-Invasive Bladder Cancer by OncoTherad® (MRB-CFI-1) Nanoimmunotherapy: Effects on Tumor-Associated Macrophages, Tumor-Infiltrating Lymphocytes, and Monoamine Oxidases - Beyond the Abstract November 20, 2024

MTAP Protein Status Is Highly Concordant with CDKN2A Fluorescent in Situ Hybridization and Allows Stratification of the Luminal Subtype in Muscle-Invasive Bladder Cancer - Beyond the Abstract November 8, 2024

Comparative Effectiveness of Bacillus Calmette-Guérin and Sequential Intravesical Gemcitabine and Docetaxel for Treatment-naïve Intermediate-risk Non-muscle-invasive Bladder Cancer - Beyond the Abstract October 21, 2024

Exposures and Bladder Cancer Risk Among Military Veterans: A Systematic Review and Meta-analysis - Beyond the Abstract October 21, 2024

Early Adjuvant Chemotherapy Improves Survival in Muscle Invasive Bladder Cancer: A Systematic Review and Meta-analysis - Beyond the Abstract October 9, 2024

Novel Therapeutic Regimens in Previously Untreated Metastatic Urothelial Carcinoma: A Systematic Review and Bayesian Network Meta-Analysis - Beyond the Abstract October 7, 2024

Perioperative and Extended Outcomes of Patients Undergoing Parastomal Hernia Repair Following Cystectomy and Ileal Conduit - Beyond the Abstract September 26, 2024

Histopathological, Molecular and Clinical Profiling of Lymphoepithelioma-Like Carcinoma of the Bladder (LELC-B) - Beyond the Abstract September 6, 2024

Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone as First-Line Treatment for Advanced Urothelial Cancer: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials - Beyond the Abstract September 3, 2024

Population Estimates of Ovarian Cancer Risk in a Cohort of Patients with Bladder Cancer - Beyond the Abstract September 3, 2024

Impact of Pathologic Re-Review on Grade, Clinical Stage, and Risk Stratification for Patients with Non-Muscle Invasive Bladder Cancer - Beyond the Abstract August 27, 2024

A Podcast on Practical Considerations in Patients with Advanced Urothelial Cancer Receiving First-Line Cisplatin- or Carboplatin-Based Chemotherapy Followed by Avelumab Maintenance in a Changing Therapeutic Landscape - Beyond the Abstract August 8, 2024

Survival of Metastatic Urothelial Carcinoma of Urinary Bladder According to Number and Location of Visceral Metastases - Beyond the Abstract August 5, 2024

Novel Delivery Systems and Pharmacotherapeutic Approaches for the Treatment of Non-muscle-invasive Bladder Cancer - Beyond the Abstract July 30, 2024

Multidisciplinary Management of Sexual and Gender Minorities with Bladder Cancer - Beyond the Abstract July 25, 2024

Use of Bladder Epicheck® in the Follow-up of High-Risk Non-Muscle-Invasive Bladder Cancer: A Systematic Literature Review - Beyond the Abstract July 24, 2024

Page 1 of 24